The London skyline at sunrise, for a report on cancer screening and a study of trans people in England

NewsroomTrans advocacyNews

Cancer Cases Among Trans People Could More Than Double in a Decade

A study published November 19 estimates that new cancer cases among trans and gender-diverse people in England could rise from about 965 a year to about 2,257 within 10 years.

The study was led by researchers at Queen Mary University of London.

New cancer cases among transgender and gender-diverse people in England could more than double in the next decade, from about 965 a year now to about 2,257 a year within 10 years, a study published on November 19, 2026, estimates. Researchers at Queen Mary University of London say cancer services and cancer screening need to get ready, PinkNews reported.

The study is about England, and its numbers are modelled estimates, not counts. But its questions travel: whether trans people get invited for the right cancer screening, whether clinics feel safe, and whether health records can see the patient in front of them. Here’s what the study found, how screening works for trans people in England, and what you can do.

01

What the study found

The study was published in the medical journal eClinicalMedicine. It was billed as the first study to estimate how many new cancer cases occur each year among transgender and gender-diverse people in England, PinkNews reported.

The researchers estimated about 965 new cases a year at present. They projected that annual new cases could climb to about 1,739 in five years and about 2,257 within a decade. To build those estimates, they drew together national cancer statistics, population data and existing research on the possible effects of gender-affirming healthcare.

The Queen Mary University of London release describes the work as a simulation and projection study. Its figures match the ones PinkNews reported.

02

Which cancers the study expects

The modelling estimated that breast cancer would be the most common, at about 19% of cases. Colorectal cancer came next, at about 12%, followed by lung cancer at about 11%, according to PinkNews.

Those three cancers are the targets of familiar checks. Breast screening and bowel screening are routine programs in England, and both depend on people being invited and feeling able to go. That’s why the researchers’ call for better cancer screening matters as much as the numbers.

03

Why the numbers are rising

The researchers point to an aging population. “As this population ages, we need to ensure cancer services are prepared to meet patients’ needs,” lead author Dr. Alison Berner said, so that everyone can get appropriate screening, diagnosis and treatment.

“Our research suggests that, in England, cancer cases among transgender and gender-diverse people could more than double in the next decade,” Berner said. She called it “an important and often overlooked area of cancer care.”

Bloom reads that as a planning warning, not a panic button. Cancer risk rises with age for everyone. A community that is growing older needs cancer screening and cancer care that know how to treat it.

04

What gender-affirming care may change

The researchers also modelled what would happen if trans and gender-diverse people could get the gender-affirming care they planned to receive, such as hormone treatment and surgery. In that case, the projected number of new cancer cases in 10 years could be about 11% lower, at about 2,006, PinkNews reported.

“Cancer care is not one-size-fits-all,” co-lead author Dr. Chloe Pasin said. “Our findings suggest that gender-affirming treatments could reduce the likelihood of developing some cancers, while potentially increasing the risk of others.”

That nuance matters. Gender-affirming care isn’t a cancer treatment, and the study doesn’t claim it is. It suggests that a person’s care history changes their risk, which is exactly why cancer screening has to be fitted to the person.

05

The data problem

The study found a gap in the records. Cancer registration systems don’t reliably separate sex characteristics from gender identity, which makes it hard to map cancer trends among trans people and plan services, the researchers said.

“We also need better data to build a clearer picture of cancer risks among transgender and gender-diverse people,” Pasin said, to make sure their needs aren’t overlooked.

When records can’t tell what organs a patient has, invitations for cancer screening can go to the wrong people, or miss the right ones. A good record isn’t paperwork. It’s how a system remembers who you are.

06

Why screening is harder for trans people

The study noted that transgender and gender-diverse people may face barriers to screening and treatment, PinkNews reported. Those include concerns about discrimination, healthcare settings that don’t meet their needs, and uncertainty about whether they’re eligible for screening programs.

That matters because early checks work. Breast screening “can find cancers when they are too small to see or feel,” the NHS guidance says, and finding cancer early gives the best chance of survival.

Each of those barriers can turn a routine invitation into a skipped appointment. A trans man who is still due for cervical screening may never get a letter. A trans woman may not know she can ask for breast screening. And anyone who has been mistreated in a clinic may simply stay away.

The researchers called for improvements in cancer screening, training for healthcare professionals and better collection of patient data. None of those needs a new law. They need attention.

07

How NHS cancer screening works for trans people

England’s NHS publishes screening guidance for trans and non-binary people. Invitations generally follow how a person is registered with their GP, so the guidance explains what each group is offered.

For breast screening, people registered with a GP as female are invited automatically from age 50 up to their 71st birthday, every three years. People registered as male can’t have mammograms through the national program, the guidance says, but their GP can refer them for mammograms at a hospital.

For cervical screening, people aged 25 to 64 registered as female are invited routinely. Trans men and non-binary people assigned female at birth who are registered as male aren’t invited automatically, but they can “opt in” to routine invitations by contacting a screening provider such as their GP, a sexual health clinic or a gender clinic.

08

Breast screening and hormones

The NHS guidance speaks directly to trans women and non-binary people assigned male at birth. “Long-term hormone therapy can increase your risk of developing breast cancer,” it says, so people registered as female should consider going for breast screening when they’re invited.

Trans women who are registered with a GP as male won’t be invited for breast screening. If they’ve been on long-term hormone therapy, the guidance says, their GP can arrange a referral for mammograms at a hospital.

For trans men and non-binary people assigned female at birth, the guidance depends on surgery. People who haven’t had chest reconstruction, or who still have breast tissue, are encouraged to consider breast screening. Those registered as male who are 50 or older can ask their GP for a hospital referral.

09

Cervical screening, explained

Cervical screening checks a small sample of cells from the cervix for high-risk types of human papillomavirus, or HPV, the NHS guidance says. If those types aren’t found, the person is recalled in five years.

People with a cervix who are registered as male aren’t invited automatically. The guidance says they “should still consider” cervical screening if they haven’t had a total hysterectomy, and they can opt in to routine invitations.

For trans women and non-binary people assigned male at birth, the guidance is simple: they don’t need cervical screening, because they don’t have a cervix, even if a letter arrives.

10

Bowel screening and other checks

Bowel cancer screening is offered every two years to people aged 50 to 74, the NHS guidance says. It starts with a test kit used at home, and trans and non-binary people are invited whatever their GP registration. If the kit finds signs that need a closer look, the next step is a colonoscopy, and the guidance notes that it may be more uncomfortable for people who have had gender reassignment surgery. Knowing that ahead of time can make the follow-up less frightening.

The guidance also covers screening for abdominal aortic aneurysm, a swelling of the body’s main artery. Trans women and non-binary people assigned male at birth who are registered as female aren’t routinely invited, the guidance says, but can request it.

The NHS guidance says people should be “treated with dignity and respect at all times.” It notes that you can ask for an appointment at the beginning or end of a clinic if that makes cancer screening easier to face.

11

Cancer screening ages in England

The NHS guidance sets out when each routine cancer screening program begins and ends. Here are the ages it lists:

  • 25 to 64: cervical screening for people registered as female, and for people who opt in, generally every five years
  • 50 up to the 71st birthday: breast screening for people registered as female, every three years
  • 50 to 74: bowel cancer screening for everyone, every two years, with a home test kit
  • 75 and over: a bowel screening kit on request, every two years

If your records don’t match your body, these ages are where cancer screening can slip through the cracks. Mark them, and ask about the ones that apply to you.

12

What the study can’t tell us

The researchers’ figures are modelled estimates, built from existing statistics and research, not a count of diagnosed cases. They apply to England, where the national health service runs invitation-based cancer screening programs.

The study can’t say how many trans people in any other country will develop cancer. It doesn’t tell any one person what their risk is. And it relies on data that the researchers themselves say is incomplete.

Those limits don’t make the warning less useful. They make the call for better data more urgent.

13

Questions to ask about cancer screening

If you’re trans or non-binary, these questions can help you and your doctor build a cancer screening plan. They’re drawn from the NHS guidance and the study’s findings:

  • Which cancer screening tests fit my body and my age?
  • Will my records send me the right invitations, or do I need to opt in?
  • Does my hormone history change my risk, or the cancer screening I should have?
  • If I’ve had surgery, what tissue or organs still need checking?
  • Can I book a time or place that makes the appointment easier for me?

Bring the answers home and keep them with your health papers. A written plan is easier to follow than a letter that may never come.

14

Why this matters to Bloom

Trans people deserve the same chance to catch cancer early as anyone else. That chance depends on cancer screening that sees them accurately, and on clinics where they’re treated with respect.

This study puts numbers on a worry many trans elders have carried for years. Growing older is a gift. It also means more check-ups, and more chances for a system to get things wrong.

Bloom will keep reporting on trans health as research and policy change, in England and at home.

15

What this means for trans readers everywhere

Bloom serves readers in the United States and around the world, and screening systems differ from country to country. But the lessons from this study apply anywhere: screening should follow the body and history you have, and the records that send invitations should be right.

If your doctor’s records list your gender, ask how that affects which cancer screening reminders you get. If you’ve had surgery or take hormones, tell your doctor, so your screening plan fits you.

Bloom believes no one should skip a test that could save their life because a waiting room didn’t feel safe. That’s a problem clinics can fix.

16

What trans people can do now

Cancer screening only works if you go, and if the right tests reach you. These steps come from the NHS guidance and the study’s findings. They don’t replace your own doctor’s advice:

  1. Know which tests fit your body. Breast, cervical and bowel cancer screening depend on your organs and age, not on your gender.
  2. Check your records. In England, invitations follow how you’re registered with your GP. Ask your GP how your records affect your invitations.
  3. Ask to opt in or request screening. The NHS guidance says trans men registered as male can opt in to cervical screening, and people registered as male can be referred for mammograms.
  4. Ask for what helps you feel safe. The guidance says you can ask for an appointment at the beginning or end of a clinic.
  5. Tell your doctor about your care. Hormones and surgery can change which cancer screening you need.

17

What happens next

The researchers called for cancer services to prepare, for better cancer screening, for training and for better data. Whether the NHS acts on those recommendations is the next question.

Better records would help most. If registries could separate sex characteristics from gender identity, as the researchers urge, cancer screening invitations and cancer statistics could both become more accurate. That would help trans patients and the doctors who care for them.

Bloom has reported on research that matters to trans people’s health, including a JAMA Pediatrics study finding transition regret is rare and a ruling on HIV care for transgender patients. We’ll keep following the evidence.

18

What Bloom is doing

Bloom stands with trans people at every age, including the years when check-ups matter most. I believe getting older as a trans person is a gift worth protecting, and good cancer screening is part of how we protect it.

If this news is heavy for you, Bloom’s crisis support page lists people you can call any hour, including Trans Lifeline at 877-565-8860. Bloom’s support groups are a place to talk it through.

A monthly gift keeps Bloom reporting the research that shapes trans health, and a one-time gift helps too.

19

Frequently Asked Questions

It estimated that new cancer cases among transgender and gender-diverse people in England could rise from about 965 a year to about 1,739 in five years and about 2,257 within 10 years.

It was published in the journal eClinicalMedicine on November 19, 2026, by researchers led by Queen Mary University of London.

Breast cancer was estimated at about 19% of cases, colorectal cancer at about 12% and lung cancer at about 11%.

The researchers say it could reduce the likelihood of some cancers while potentially increasing the risk of others. With planned care, they projected about 11% fewer cases in 10 years.

Invitations generally follow how a person is registered with their GP. People registered as male can opt in to cervical screening if they have a cervix, and can be referred for mammograms.

The NHS guidance says long-term hormone therapy can increase breast cancer risk, so trans women invited for breast screening should consider going. Those registered as male can ask their GP for a referral.

No. It’s a modelling study that estimates cases from national statistics, population data and existing research, and it applies to England.

Sovereignty over Servitude. 🌸

Support this work

Everything Bloom publishes is free to read and free to share.

Bloom Ministries is a registered 501(c)(3) in Salem, Oregon. Monthly giving is what lets us say yes before the money is in hand.

Give monthlyGive onceGifts are tax-deductible to the extent allowed by law.